医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Aderans Completes Acquisition of Hair Club, Expands Services in US Hair Replacement Market

2013年04月10日 AM08:25
このエントリーをはてなブックマークに追加


 

TOKYO & BEVERLY HILLS, Calif.

Aderans Co, Ltd. (“Aderans”)(T.8170) announced today that it completed the acquisition of Hair Club, a leader in the North American hair replacement services market, for $163.5 million.

“We are pleased to complete the acquisition of Hair Club and warmly welcome Hair Club customers, employees and franchisees to the Aderans group,” said Nobuo Nemoto, founder and representative director of Aderans. “Aderans continues to focus on profitable ways to grow revenues across the globe.”

Headquartered in Tokyo, Japan, Aderans is a global provider of hair replacement and restoration products and services, owning internationally-recognized brands ADERANS for men and women, FONTAINE for women, BOSLEY, a provider of hair loss solutions and medical hair restoration and now HAIR CLUB, the leading North American “all proven solutions provider” of hair restoration services for men and women.

“The acquisition of Hair Club significantly grows Aderans’ North American revenues. By bringing together Bosley and Hair Club, Aderans now has the largest network of surgical and non-surgical hair restoration services in North America,” said Joshua Schechter, Chairman of Aderans America Holdings, Inc. “We will now focus on combining the best practices of Bosley, Hair Club and Aderans in order to provide the best experience and results for our customers.”

About Aderans:

Founded in 1969, Aderans is a global provider of hair replacement and restoration products and services, whose internationally-recognized brands include ADERANS custom-made wigs, hair products and services for men, FONTAINE custom-made and ready-to-wear wigs, products and services for women, BOSLEY, providing hair loss solutions and medical hair restoration and HAIR CLUB, the leading all proven solutions provider of hair restoration services for men and women.

CONTACT

Sitrick And Company
Jason Booth, 1-310-788-2850
Jason_Booth@Sitrick.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions
  • Taiwan Innotech Expo (TIE) Showcases Strong Ecosystems in the Post-Pandemic World
  • Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market
  • GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise
  • 随着越来越多的客户和合作伙伴使用Denodo冠状病毒数据门户计划来对抗和最小化COVID-19的影响,其采纳率在不断提高